4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-22-084763
President, CEO acquired 101,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gilad Oren President, CEO | 2022-07-28 | Grant or award | +101,300 | 330,314 | D | ||
| Derivatives | |||||||
| Gilad Oren President, CEO | 2022-07-28 | Grant or award · Stock Option (right to Buy) | +148,700 | 148,700 | D | ||
Loading xslF345X03/tm2222147-3_4seq1.xml…